FCM
KYMR icon

Frontier Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Frontier Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.3M Buy
759,848
+123,891
+19% +$9.81M 0.65% 38
2025
Q4 		$49.5M Buy
635,957
+117,900
+23% +$7.96M 0.53% 56
2025
Q3 		$29.3M Buy
518,057
+26,247
+5% +$1.18M 0.26% 140
2025
Q2 		$21.5M Buy
491,810
+359,847
+273% +$12.4M 0.2% 178
2025
Q1 		$3.61M Sell
131,963
-18,209
-12% -$664K 0.04% 264
2024
Q4 		$6.04M Sell
150,172
-242,091
-62% -$10.9M 0.06% 249
2024
Q3 		$18.6M Buy
+392,263
New +$17.3M 0.17% 175

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return